TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 213 filers reported holding TURNING POINT THERAPEUTICS I in Q2 2022. The put-call ratio across all filers is 3.08 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $252,000 | -41.8% | 9,403 | +3.5% | 0.08% | -31.0% |
| Q4 2021 | $433,000 | +8.2% | 9,083 | +50.8% | 0.11% | +3.7% |
| Q3 2021 | $400,000 | -32.9% | 6,023 | -21.2% | 0.11% | -35.5% |
| Q2 2021 | $596,000 | 0.0% | 7,643 | +21.3% | 0.17% | -7.7% |
| Q1 2021 | $596,000 | -13.5% | 6,303 | +11.5% | 0.18% | -15.3% |
| Q4 2020 | $689,000 | +25.5% | 5,653 | -10.0% | 0.22% | +7.5% |
| Q3 2020 | $549,000 | +31.7% | 6,283 | -2.6% | 0.20% | +21.8% |
| Q2 2020 | $417,000 | – | 6,450 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 708,233 | $44,116,000 | 18.91% |
| Corriente Advisors, LLC | 285,000 | $17,753,000 | 9.54% |
| Cormorant Asset Management, LP | 3,396,650 | $211,577,000 | 8.44% |
| Opaleye Management Inc. | 340,500 | $21,210,000 | 4.16% |
| Orbimed Advisors | 2,745,327 | $171,006,000 | 2.44% |
| Parkman Healthcare Partners LLC | 101,434 | $6,318,000 | 1.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,000 | $2,179,000 | 0.78% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 366,000 | $22,798,000 | 0.73% |
| Artal Group S.A. | 300,000 | $18,687,000 | 0.72% |
| DAFNA Capital Management LLC | 30,408 | $1,894,000 | 0.65% |